Drug Approval | March 01, 2024
Biocon Biologics secures US market entry date for Bmab 1200
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
BHL will undertake the development and supply of these molecules
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Global Initiative on Digital Health (GIDH) was launched by the WHO and the Government of India during the G20 Health Working Group meeting in Gandhinagar last year
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Subscribe To Our Newsletter & Stay Updated
